If you made any changes in Pure these will be visible here soon.

Research Output 1989 2019

Filter
Comment / Debate
2015

C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases

Chong, Y-P., Chan, A. S., Chan, K. C., Williamson, N. A., Lerner, E. C., Smithgall, T. E., Bjorge, J. D., Fujita, D. J., Purcell, A. W., Scholz, G., Mulhern, T. D. & Cheng, H-C., 2 Jan 2015, In : Journal of Biological Chemistry. 290, 1, p. 240 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2010
1 Citation (Scopus)

Enhancing tumor vaccines: Catalyzing MHC class II peptide exchange

Croft, N. P. & Purcell, A. W., Feb 2010, In : Expert Review of Vaccines. 9, 2, p. 129-132 4 p.

Research output: Contribution to journalComment / DebateResearchpeer-review

2009

A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))

Ebert, L. M., Liu, Y. C., Clements, C. S., Robson, N. C., Jackson, H. M., Markby, J. L., Dimopoulos, N., Tan, B. S., Luescher, I. F., Davis, I. D., Rossjohn, J., Cebon, J., Purcell, A. W. & Chen, W., 15 May 2009, In : Cancer Research. 69, 10, p. 4553 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2008
1 Citation (Scopus)

Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity (DOI: 10.1016/j.immuni.2008.04.020)

Chessman, D., Kostenko, L., Lethborg, T., Purcell, A. W., Williamson, N. A., Chen, Z., Kjer-Nielsen, L., Mifsud, N. A., Tait, B. D., Holdsworth, R., Almeida, C. A., Nolan, D., Macdonald, W. A., Archbold, J. K., Kellerher, A. D., Marriott, D., Mallal, S., Bharadwaj, M., Rossjohn, J. & McCluskey, J., 18 Jul 2008, In : Immunity. 29, 1, 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review